As filed with the Securities and Exchange Commission on October 3, 2022
Registration No. 333-232365
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-8 REGISTRATION STATEMENT (No.
333-232365)
UNDER
THE SECURITIES ACT OF 1933
Change
Healthcare Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Delaware |
|
83-2152098 |
(State or Other Jurisdiction
of Incorporation or Organization) |
|
(I.R.S. Employer
Identification No.) |
424 Church Street, Suite 1400
Nashville, TN 37219
(615) 932-3000
(Address, including zip code, and telephone, including area code, of registrants principal executive offices)
Change Healthcare Inc. 2019 Omnibus Incentive Plan
Change Healthcare Inc. 2019 Employee Stock Purchase Plan
Amended and Restated HCIT Holdings, Inc. 2009 Equity Incentive Plan
(Full Title of the Plans)
Neil E. de Crescenzo
President and Chief Executive Officer
Change Healthcare Inc.
424 Church Street, Suite 1400
Nashville, TN 37219
Telephone: (615) 932-3000
(Name, address, including zip code, and telephone number, including area code, of agent for service)
With copies to:
Joshua Ford Bonnie
William R. Golden III
Simpson Thacher & Bartlett LLP
900 G Street, N.W.
Washington, D.C. 20001
(202) 636-5500
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated
filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐